Clinical applications of procalcitonin (ProCT)

Journal of Internal Medicine of Taiwan

Volumn 17, Issue 1, 2006, Pages 1-10

  Yang, Ching Huei ^a   Lu, Daniel C T ^a  

^a LOTUNG POH AI HOSPITAL   (Taiwan)

Author keywords

Biomarker; Immunoneutralization; Procalcitonin; ProCT

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; PROGNOSIS; SEPSIS;

EID: 33646264549     PISSN: 10167390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38: 483-93.
2. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005; 11: 473-80.
3. Martinez JM, Becker KL, Muller B, et al. Improved physiologic and metabolic parameters and increased survival with late procalcitonin immunoneutralization in septic pigs. 41st Interscience Conference on Antimicrobial Agnest and Chemotherapy (ICAAC) 2001, Chicago, IL: (abstract)
4. Le Moullec JM, Julliene A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett 1984; 167: 93-7.
5. Broad PM, Symes AJ, Hakker RV, et al. Structure and methylation of the human calcitonin/alpha-CGRP gene. Nucleic Acids Res 1989; 17: 6999-7011.
6. Tabassian AR, Nylen ES, Linoila IR, et al. Stimulation of hamster pulmonary neuroendocrine cells and associated peptides by repeated exposure to cigarette smoke. Am Rev Respir Dis 1989; 140: 436-40.
7. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
8. Muller Beat, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977-83.
9. Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578-84.
10. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002; 323: 1702-9.
11. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin -guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-7.
12. Snider RH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 1997; 45: 552-60.
13. Meisner M, Brunkhorst FM, Reith HB, et al. Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 2000; 38: 989-95.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
15. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.
16. Delevaux I, Andre M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62: 337-40.
17. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS Internaltional Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
18. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
19. Duflo F, Debon R, Monneret G, et al. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002; 96: 74-9.
20. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 48-53.
21. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systemic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17.
22. Chirouze C, Schuhmacher H, Christian R, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002; 35: 156-61.
23. Viallon A, Guyomarch P, guyomarch S, et al. Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care 2005; 9: 344-50.
24. Blazer S, Berant M, Alon U. Bacterial meningitis. Effect of antibiotic treatment on cerebrospinal fluid. Am J Clin Pathol 1983; 80: 386-7.
25. Greaves K, Mou D, Patel A, et al. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003; 89: 273-5.
26. Mueller C, Huber P, Laifer G, et al. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004; 109: 1707-10.
27. Lemprinen M, Puolackkannen P, Kemppainen F. Clinical value of severity markers in acute pancreatitis. Scand J Surg 2005; 94: 118-23
28. Rau B, Schilling MK, Beger HG. Laboratory markers of severe acute pancreatitis. Dig Dis 2004; 22: 247-57.
29. Benador N, Siegrist CA, Gendrel D, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998; 102: 1422-5.
30. Pecile P, Miorin E, Romanello C, et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004; 114: 249-54.
31. Davis TM, Assicot M, Bohuon C, et al. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994; 88: 670-1.
32. Reith HB, Mitttelkotter U, Debus ES, et al. Procalcitonin in early detection of postoperative complications. Dig Surg 1998; 15: 260-5.
33. Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24: 680-4.
34. Siassi M, Riese J, Steffensen R, et al. Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care 2005; 9: 483-9.
35. Eberhard OK, Langefeld I, Kuse ER, et al. Procalcitonin in the early phase after transplantation-will it all to diagnostic accuracy? Clin Transplant 1998; 12: 206-11.
36. Staehler C, Hammer C, Meiser B, et al. Procalcitonin: A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation. Transplant Proc 1997; 29: 584-5.
37. Muller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001; 131: 595-602.
38. Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005; 135: 451-60.
39. Sorbera LA. Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis. Highlights from the 25th International Symposium on Intensive Care and Emergency Medicine. March 21-25, 2005, Brussels, Belgium. Drugs Today 2005; 41: 253-6.